Volume 28, Issue 4 (Monthly_Jul 2017)                   J Urmia Univ Med Sci 2017, 28(4): 16-21 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

norouzi N, Bonyadi M, Babaei E, Jabbarpour Bonyadi M H, Javadzadeh A. Association of CFI gene polymorphism with age related macular degeneration in Northwest of Iran. J Urmia Univ Med Sci. 2017; 28 (4) :16-21
URL: http://umj.umsu.ac.ir/article-1-3457-en.html
Tabriz of University , jabbarpour@tabrizu.ac.ir
Abstract:   (1394 Views)

Background & Aims: To investigate the association of CFI p.Gly119Arg polymorphism with Age-related macular degeneration (AMD).

Materials & Methods: In this case-control study, the association of p.Gly119Arg polymorphism in CFI gene was investigated in 65 patients suffering from AMD and150 healthy age, sex and ethnicity matched unrelated people as control group. Both of the case and control groups were originated from Northwest of Iran. Genotypes of both groups were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).

Results: Investigation of the association of p.Gly119Arg polymorphism in CFI gene with AMD showed that there are no statistically significant differences between patients and controls in genotype and allele frequencies of this polymorphism (P˃0/05).

Conclusion: Our result show that p.Gly119Arg polymorphism of the CFI gene is unrelated to the susceptibility to AMD in Northwest of Iran.

Keywords: AMD, polymorphism, CFI gene
Full-Text [PDF 239 kb]   (374 Downloads)    
Type of Study: Research | Subject: ژنتیک

1. 1. Holliday EG, Smith AV, Cornes BK, Buitendijk GH, Jensen RA, Sim X, et al. Insights into the Genetic Architecture of Early Stage Age-Related Macular Degeneration:A Genome-Wide Association Study Meta-Analysis. Plos One 2013;8 (1):e52830.
2. 2. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995; 39:367–74.
3. 3. Lu F, Zhao P, Fan Y, Tang S, Hu J, Liu X, et al. An association study of SERPING1 gene and agerelated macular degeneration in a Han Chinese population. Mol Vis 2010;16:1.
4. 4. Thakkinstian A, McKay GJ, McEvoy M, ChakravarthyU, Chakrabarti S, Silvestri G, et al. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 2011;173(12):1365-79.
5. 5. Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinic opathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 1994; 14:130–42.
6. 6. Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Investig Ophthalmol Vis Sci 2007; 48:968–77.
7. 7. Ferris FL, Davis MD, Clemons TE, Lee L-Y, Chew EY, Lindblad AS, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005;123(11):1570–4.
8. 8. Ratnapriya R CE. Age-related macular degeneration – clinical review and genetics update. Clin Genet 2013;84(2):160-6.
9. 9. Bressler NM. Early Detection and Treatment of Neovascular Age-related Macular Degeneration. J Am Board Fam Pract 2002;15(2):142-52.
10. 10. Meyers SM. A twin study on age related macular degeneration. Trans Am Ophthalmology Soc 1994; 92:775-843.
11. 11. Grizzard SW, Arnett D, and Haag SL. Twin study of age-related macular degeneration. Ophthalalmic Epidemiol 2003; 10:315-22.
12. 12. Dosso AA and Bovet J Monozygotic. twin brothers with age-related macular degeneration. Ophthalmological 1992; 205:24-8.
13. 13. Walport, M.J. Complement First of two parts. N Engl J Med 2001.344, 1058–66.
14. 14. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, et al. Drusen proteome analysis: an approach to the etiology of age related macular degeneration. Proc Natl Acad Sci USA 2002;99:14682–7.
15. 15. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science 2005;308(5270):384-9.
16. 16. Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Gene 2009;46(5):300-7.
17. 17. Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM. Complement factor I in health and disease. Mol Immunol 2011;48(14):1611-20.
18. 18-Wang J, Ohno-Matsui K, Yoshida T, Kojima A, Shimada N, Nakahama K, et al. Altered function of factor I caused by amyloid beta: implication for pathogenesis of age-related macular degeneration. J Immunol 2008; 181:712-20.
19. 19. Kociok, N., Joussen, A.M. Enhanced expression of the complement factor H mRNA in proliferating human RPE cells. Arch Ophthalmol 2010; l(248): 1145–53.
20. 20. Smith C. Genomics: SNPs and human disease. Nature 2005;435(7044):993.
21. 21. Van de Ven JP, Nilsson SC, Tan PL, Buitendijk GH, Ristau T, Mohlin FC, et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet 2013; 45:813-7.
22. 22. Hohenester, E., Sasaki, T. & Timpl, R. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat Struc Mol Biol 1999; 6, 228–32.
23. 23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.
24. 24. Swaroop A., Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009;10: 19-43.
25. 25. Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 2006;103(7):2328–33.
26. 26. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000;14(7):835–46.
27. 27. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma Complement Components and Activation Fragments: Associations with Age-Related Macular Degeneration Genotypes and Phenotypes. Investig ophthalmol Vis Sci 2009;50(12): 5818-27.
28. 28. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010;107(16):7395–400.
29. 29. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 2009;17: 100–4.
30. 30. Ennis S, Gibson J, Cree AJ, Collins A, Lotery AJ: Support for the involvement of complement factor I in age-related macular degeneration. Eur J Hum Genet 2010; 18: 15–6.
31. 31. Philip Alexander, Jane Gibson, Angela J. Cree, Sarah Ennis, Andrew J. Lotery; Complement factor I and age-related macular degeneration. Mol Vis 2014; 20: 1253–7.

Add your comments about this article : Your username or Email:

Send email to the article author

© 2018 All Rights Reserved | URMIA MEDICAL JOURNAL

Designed & Developed by : Yektaweb